Title |
Host–pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity
|
---|---|
Published in |
Infection and Drug Resistance, September 2014
|
DOI | 10.2147/idr.s53700 |
Pubmed ID | |
Authors |
Don J Steiner, Yoichi Furuya, Dennis W Metzger |
Abstract |
Francisella tularensis is an intracellular Gram-negative bacterium that causes life-threatening tularemia. Although the prevalence of natural infection is low, F. tularensis remains a tier I priority pathogen due to its extreme virulence and ease of aerosol dissemination. F. tularensis can infect a host through multiple routes, including the intradermal and respiratory routes. Respiratory infection can result from a very small inoculum (ten organisms or fewer) and is the most lethal form of infection. Following infection, F. tularensis employs strategies for immune evasion that delay the immune response, permitting systemic distribution and induction of sepsis. In this review we summarize the current knowledge of F. tularensis in an immunological context, with emphasis on the host response and bacterial evasion of that response. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Sweden | 1 | 1% |
Unknown | 81 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 16 | 19% |
Researcher | 13 | 16% |
Student > Bachelor | 12 | 14% |
Student > Master | 10 | 12% |
Student > Doctoral Student | 4 | 5% |
Other | 11 | 13% |
Unknown | 17 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 23 | 28% |
Immunology and Microbiology | 17 | 20% |
Biochemistry, Genetics and Molecular Biology | 11 | 13% |
Medicine and Dentistry | 4 | 5% |
Veterinary Science and Veterinary Medicine | 3 | 4% |
Other | 5 | 6% |
Unknown | 20 | 24% |